Novel apoptosis assay to analyze immunosuppression

9Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Background: We developed a novel whole blood assay to assess the effects of immunosuppressants on lymphocyte apoptosis. Methods: Peripheral blood for six experiments for each drug was treated either with cyclosporin A (CsA), mycophenolate acid (MPA), tacrolimus (TRL) or rapamycin (RAPA). Whole blood was stimulated with different concentrations of staurosporine (0-5 μM) for 24 h. Using FACS, apoptosis were measured by Annexin V expression (%cells ± SEM). Results: MPA, RAPA, TRL, but not CsA, increased (P < 0.05) apoptotic cells (MPA:20.9 ± 3.7; RAPA:17.5 ± 3.3; TRL:16.4 ± 2.9 vs. control:15.2 ± 2.8). Conclusion: This new whole blood assay exhibited that MPA has a stronger effect on apoptosis than RAPA and TRL, whereas CsA had no effect. © 2006 International Society for Analytical Cytology.

Cite

CITATION STYLE

APA

Boldt, A., Barten, M. J., Weiss, C., Sagner, A., Mohr, F. W., & Gummert, J. F. (2006). Novel apoptosis assay to analyze immunosuppression. Cytometry Part A, 69(3), 158–160. https://doi.org/10.1002/cyto.a.20218

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free